Showing 101 - 120 results of 15,103 for search '(( ((a latest) OR (a latent)) decrease ) OR ((( b large increases ) OR ( a largest decrease ))))', query time: 0.54s Refine Results
  1. 101

    Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
  2. 102

    Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118

    Class I SLA expression is increased in the TSST-1 stimulated CD4+ cells. by Shino Ohshima (3229245)

    Published 2020
    “…The left two panels show the representative pattern of FSC/SSC after 72 hrs of culture with/without TSST-1 stimulation. As the large cells are increased by TSST-1 stimulation, a small and large lymphocyte gate was used for the analysis. …”
  19. 119
  20. 120

    Table_1_Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma.XLSX by Wei Qin (205374)

    Published 2021
    “…<p>The clinical and molecular characteristics of localized diffuse large B-cell lymphoma (DLBCL) with single nodal (SN) or single extranodal (SE) involvement remain largely elusive in the rituximab era. …”